Vertex Pharmaceuticals Incorporated Stock News

Amazon is well positioned to remain a leader in e-commerce and cloud services. Brookfield Renewable has almost sure-fire growth prospects with the rising demand for renewable energy.

AI should provide a huge tailwind for Alphabet. MercadoLibre has major growth opportunities in Latin America's e-commerce and fintech markets.

Eli Lilly is growing by leaps and Zepbounds. Novo Nordisk is just getting warmed up after delivering a 53% gain last year.

Brenda Vingiello, Sand Hill Global Advisors CIO, Bryn Talkington, Requisite Capital Management managing partner, Jim Lebenthal, Cerity Partners chief equity strategist, and Josh Brown, Ritholtz Wealth

In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $421.01, indicating a +0.45% shift from the previous trading day.

Vertex Pharmaceuticals Incorporated (VRTX) J.P. Morgan 42nd Annual Healthcare Conference

Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Puma Biotech (PBYI) and Vertex Pharmaceuticals (VRTX). But which of these two stocks offers value investors a

Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic differences.

Vertex has a huge competitive advantage in its core franchise, where it still has room to grow. It's also developing new medicines elsewhere and recently landed an important approval.

Vertex Pharmaceuticals' cystic fibrosis franchise is successful, but it's also running out of room to grow. Expected results from a trial with an experimental pain reliever called VX-548 could push Ve

Gen Z stocks aren't typical, because the generation has a unique relationship with the stock market. Just like Gen Z is the first to grow up fully immersed in digitization and the Internet culture, ac

Betting on healthcare's future via healthcare stocks is one of the safest long-term bets you can make. Though changes and advances happen rapidly, healthcare is one industry that is here to stay.

As we break into the new year, investors are on the hunt for the best biotech stocks to buy. Indeed, 2024 could witness groundbreaking advancements in technology and science.

Gene-editing companies are making headlines for the potential to reshape the future of healthcare and the treatment of hereditary diseases. The U.S. Federal Drug Administration (FDA) approved a sickle